Literature DB >> 18718352

Oculomotor deficits indicate the progression of Huntington's disease.

Stephen L Hicks1, Matthieu P A Robert, Charlotte V P Golding, Sarah J Tabrizi, Christopher Kennard.   

Abstract

The oculomotor deficits associated with Huntington's Disease (HD) are one of the earliest signs of disease onset. They include a marked delay in executing voluntary saccades and a difficulty inhibiting saccades to task-irrelevant stimuli. In addition, HD patients develop a deficit in task-switching, which can be demonstrated by the continued adherence to a rule after it has been recently changed. These deficits are likely to be the result of a progressive neural degeneration of the fronto-striatal system, which is a distinguishing feature of HD neuropathology. It is predicted that as the disease progresses the magnitude of these specific deficits should increase. We tested a cohort of early HD patients and presymptomatic HD gene carriers on a series of oculomotor tasks designed to measure saccade initiation, inhibition and rule switch cost. Saccadic latencies and error rates in early HD patients were found to be systematically higher than controls. Presymptomatic HD subjects showed small increases in saccadic latencies and error rates that were in proportion to the predicted age of disease onset. These results suggest that saccadometry and a cognitively demanding oculomotor task may be useful as an indicator of function in HD.

Entities:  

Mesh:

Year:  2008        PMID: 18718352     DOI: 10.1016/S0079-6123(08)00678-X

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  21 in total

1.  Huntington's disease: changes in saccades and hand-tapping over 3 years.

Authors:  Chrystalina A Antoniades; Zheyu Xu; Sarah L Mason; R H S Carpenter; Roger A Barker
Journal:  J Neurol       Date:  2010-06-29       Impact factor: 4.849

Review 2.  The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease.

Authors:  Ignacio Munoz-Sanjuan; Gillian P Bates
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

3.  Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.

Authors:  Rachael I Scahill; Nicola Z Hobbs; Miranda J Say; Natalie Bechtel; Susie M D Henley; Harpreet Hyare; Douglas R Langbehn; Rebecca Jones; Blair R Leavitt; Raymund A C Roos; Alexandra Durr; Hans Johnson; Stéphane Lehéricy; David Craufurd; Christopher Kennard; Stephen L Hicks; Julie C Stout; Ralf Reilmann; Sarah J Tabrizi
Journal:  Hum Brain Mapp       Date:  2011-11-18       Impact factor: 5.038

4.  Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease.

Authors:  Jason Rupp; Mario Dzemidzic; Tanya Blekher; John West; Siu Hui; Joanne Wojcieszek; Andrew J Saykin; David A Kareken; Tatiana Foroud
Journal:  J Neurol       Date:  2011-08-18       Impact factor: 4.849

5.  Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease.

Authors:  Jason Rupp; Mario Dzemidzic; Tanya Blekher; Veronique Bragulat; John West; Jacqueline Jackson; Siu Hui; Joanne Wojcieszek; Andrew J Saykin; David Kareken; Tatiana Foroud
Journal:  Neuropsychology       Date:  2011-05       Impact factor: 3.295

6.  Behavioral measures of saccade latency and inhibition in manifest and premanifest Huntington's disease.

Authors:  Travis H Turner; Jody Goldstein; Joanne M Hamilton; Mark Jacobson; Eva Pirogovsky; Guerry Peavy; Jody Corey-Bloom
Journal:  J Mot Behav       Date:  2011-06-24       Impact factor: 1.328

7.  Detection of third and sixth cranial nerve palsies with a novel method for eye tracking while watching a short film clip.

Authors:  Uzma Samadani; Sameer Farooq; Robert Ritlop; Floyd Warren; Marleen Reyes; Elizabeth Lamm; Anastasia Alex; Elena Nehrbass; Radek Kolecki; Michael Jureller; Julia Schneider; Agnes Chen; Chen Shi; Neil Mendhiratta; Jason H Huang; Meng Qian; Roy Kwak; Artem Mikheev; Henry Rusinek; Ajax George; Robert Fergus; Douglas Kondziolka; Paul P Huang; R Theodore Smith
Journal:  J Neurosurg       Date:  2014-12-12       Impact factor: 5.115

8.  The impact of oculomotor functioning on neuropsychological performance in Huntington disease.

Authors:  Janessa O Carvalho; Jeffrey D Long; Holly J Westervelt; Megan M Smith; Jared M Bruce; Ji-In Kim; James A Mills; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2016       Impact factor: 2.475

Review 9.  Eye movements in patients with neurodegenerative disorders.

Authors:  Tim J Anderson; Michael R MacAskill
Journal:  Nat Rev Neurol       Date:  2013-01-22       Impact factor: 42.937

10.  Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Authors:  Sarah J Tabrizi; Douglas R Langbehn; Blair R Leavitt; Raymund Ac Roos; Alexandra Durr; David Craufurd; Christopher Kennard; Stephen L Hicks; Nick C Fox; Rachael I Scahill; Beth Borowsky; Allan J Tobin; H Diana Rosas; Hans Johnson; Ralf Reilmann; Bernhard Landwehrmeyer; Julie C Stout
Journal:  Lancet Neurol       Date:  2009-07-29       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.